![](/img/cover-not-exists.png)
Risk of interstitial lung disease with gefitinib and erlotinib in advanced non-small cell lung cancer: A systematic review and meta-analysis of clinical trials
Shi, Liang, Tang, Junfang, Tong, Li, Liu, ZheVolume:
83
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/j.lungcan.2013.11.016
Date:
February, 2014
File:
PDF, 1.01 MB
english, 2014